Is primary prevention of Clostridium difficile infection possible with specific probiotics?
about
Comparison of pediatric and adult antibiotic-associated diarrhea and Clostridium difficile infectionsWSES guidelines for management of Clostridium difficile infection in surgical patientsLactobacillus acidophilus CL1285, Lactobacillus casei LBC80R, and Lactobacillus rhamnosus CLR2 (Bio-K+): Characterization, Manufacture, Mechanisms of Action, and Quality Control of a Specific Probiotic Combination for Primary Prevention of ClostridiProbiotics for the prevention of antibiotic-associated diarrhea and Clostridium difficile infection among hospitalized patients: systematic review and meta-analysisAdvances in the Microbiome: Applications to Clostridium difficile InfectionInfluence of Saccharomyces boulardii CNCM I-745on the gut-associated immune systemYield improvement of exopolysaccharides by screening of the Lactobacillus acidophilus ATCC and optimization of the fermentation and extraction conditionsAlteration of the intestinal microbiome: fecal microbiota transplant and probiotics for Clostridium difficile and beyond.Progress in the discovery of treatments for C. difficile infection: A clinical and medicinal chemistry review.Clostridium difficile: improving the prevention paradigm in healthcare settings.Prevalence and management of antibiotic associated diarrhea in general hospitalsDifferences of the Fecal Microflora With Clostridium difficile Therapies.New approaches for bacteriotherapy: prebiotics, new-generation probiotics, and synbiotics.Probiotics as adjunctive therapy for preventing Clostridium difficile infection - What are we waiting for?Probiotics for the Primary and Secondary Prevention of C. difficile Infections: A Meta-analysis and Systematic ReviewProbiotics: Prevention of Severe Pneumonia and Endotracheal Colonization Trial-PROSPECT: a pilot trialProbiotics: Prevention of Severe Pneumonia and Endotracheal Colonization Trial-PROSPECT: protocol for a feasibility randomized pilot trial.Anti-infective activities of lactobacillus strains in the human intestinal microbiota: from probiotics to gastrointestinal anti-infectious biotherapeutic agentsNovel avenues for Clostridium difficile infection drug discovery.Fidaxomicin for treatment of clostridium difficile-associated diarrhea and its potential role for prophylaxis.The host immune response to Clostridium difficile infectionPrevention of Clostridium difficile Infection With Probiotics.Pathway to Prevention of Nosocomial Clostridium difficile Infection.Clostridium difficile infection in patients with liver disease: a review.Probiotics and Fecal Microbiota Transplant for Primary and Secondary Prevention of Clostridium difficile Infection.Primary prevention of Clostridium difficile infections - how difficult can it be?Lactobacillus probiotics in the prevention of diarrhea associated with Clostridium difficile: a systematic review and Bayesian hierarchical meta-analysis.Gleaning Insights from Fecal Microbiota Transplantation and Probiotic Studies for the Rational Design of Combination Microbial Therapies.A Decade of Experience in Primary Prevention of Clostridium difficile Infection at a Community Hospital Using the Probiotic Combination Lactobacillus acidophilus CL1285, Lactobacillus casei LBC80R, and Lactobacillus rhamnosus CLR2 (Bio-K+).Clostridium difficile infection: new approaches to prevention, non-antimicrobial treatment, and stewardship.The Impact of Recurrent Clostridium difficile Infection on Patients' Prevention Behaviors.Clinical Practice Guidelines for Clostridium difficile Infection in Adults and Children: 2017 Update by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA)
P2860
Q26752760-B1C7967A-31C9-453E-BA03-992A09CE1836Q26795429-057E65EA-3877-4EE5-86D1-BB4B1274C859Q27012496-99BED16B-B1F9-445D-A169-507058C0B355Q27015021-BA68E158-F588-4765-8CD1-61BC601FFAE0Q28066362-A46A8BDF-82E0-49B4-BE81-A962B607E124Q28066899-D390A245-FC96-4171-B734-329CC9C17ECDQ28834599-61E937F5-5A97-4DBA-BF98-4F270AA6153DQ35000008-CBD90C3D-166A-41A0-84D8-BDA10063CCD2Q35044119-DA8732C1-DC01-43AA-85A2-A6D1B44BABF5Q35222472-127C0437-0409-4092-A375-CBA6BA12D34CQ35494124-DB316D35-E4E5-44CD-81FE-D7704EECF646Q35617263-2250D6E2-98A8-4537-B678-F16038500A23Q35812927-FF936E3E-59F1-4A68-8C49-8C50F14B904AQ36018176-3AF0A1CB-FC8F-4758-A94C-E13415BB01C7Q36683562-E2C5D120-3F5E-4F32-ACE6-D8535219B3DCQ37145742-177C3DF7-31F6-4E07-BF64-DCC86D751A41Q37498405-91C0637E-17AE-4D38-A250-DF1CD98813AAQ37712802-C5A68FD8-E291-4E9A-BE2A-E8D56AB84898Q38083297-55087533-297B-43C3-A021-01A41C0E3CAFQ38107547-1E20BE9D-7AA6-446D-8F02-84568CC3A379Q38244134-8C150A83-FF93-4C35-B970-7D8DB8A4275FQ38448285-7161C780-8689-441D-A4B1-C7DF93C01574Q38448294-3007875D-A4B9-4B4D-8A5B-964E5C23658FQ38600142-5F7F4C7D-BB2B-44B6-B561-0963241F0F1CQ38644810-84257293-43A9-448A-A963-CAF3A64797D3Q38739075-D0DCBAFE-FA42-470A-9A88-ED7267DB4B5EQ38778071-54555178-7B68-4649-B687-82F218DF05D9Q38794312-9451A980-2C45-4E7D-939F-059EEE9705FFQ41001486-6DD7B4A2-25C2-48CC-9DAE-CFACAC480F3CQ41990887-81C780E6-0854-44EA-A35D-28C2EA22F7DEQ41994402-54FB1A98-9ADB-4BD8-82D9-AECACD386B46Q56225357-7FC01A60-1CE4-47B1-A035-A93B1497F226
P2860
Is primary prevention of Clostridium difficile infection possible with specific probiotics?
description
2012 nî lūn-bûn
@nan
2012 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Is primary prevention of Clost ...... ible with specific probiotics?
@ast
Is primary prevention of Clost ...... ible with specific probiotics?
@en
Is primary prevention of Clost ...... ible with specific probiotics?
@nl
type
label
Is primary prevention of Clost ...... ible with specific probiotics?
@ast
Is primary prevention of Clost ...... ible with specific probiotics?
@en
Is primary prevention of Clost ...... ible with specific probiotics?
@nl
prefLabel
Is primary prevention of Clost ...... ible with specific probiotics?
@ast
Is primary prevention of Clost ...... ible with specific probiotics?
@en
Is primary prevention of Clost ...... ible with specific probiotics?
@nl
P2093
P3181
P1476
Is primary prevention of Clost ...... ible with specific probiotics?
@en
P2093
Brian Currie
Donald E. Low
Ellie J.C. Goldstein
Lynne V. McFarland
Pierre-Jean Maziade
Stuart Johnson
William Trick
P304
P3181
P356
10.1016/J.IJID.2012.06.005
P407
P577
2012-11-01T00:00:00Z